Dive into the future of personalized mental healthcare! This episode explores a groundbreaking study on DMT published in Neuropsychopharmacology, revealing how self-guided dosing could revolutionize ketamine therapy. Discover how this approach, where participants adjusted their own dose, not only allowed them to reach deep psychedelic effects but also didn’t increase negative side effects, hinting at a future of safer, more effective, and empowering treatment experiences. Learn what this means for finding your “sweet spot” in healing and the incredible potential of patient control in psychedelic medicine.

Rudin, D., Erne, L., Vogt, S. B., Müller, L., Nuraj, A., Becker, A., et al. (2024). Acute dose-dependent effects and self-guided titration of continuous N,N-dimethyltryptamine infusions in a double-blind placebo-controlled study in healthy participants. Neuropsychopharmacology, 50(6), 1008–1016. https://doi.org/10.1038/s41386-024-02041-8